ACM
CGON icon

Aster Capital Management’s CG Oncology CGON Stock Holding History

Aster Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Buy
+1,861
New +$122K 0.03% 469
2025
Q2 		– Sell
-192
Closed -$4.96K – 1107
2025
Q1 		$4.96K Buy
+192
New +$5.4K ﹤0.01% 1121

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aster Capital Management's CGON Position: Q2 2026 in Review

Aster Capital Management opened a new position in CG Oncology (CGON) in Q2 2026: 1,861 shares worth $132K. The stake represents 0.03% of the portfolio and ranks #469 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in CGON as recently as Q1 2025.

Aster Capital Management first reported a position in CGON in Q1 2025 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Aster Capital Management held 1,861 shares of CG Oncology worth $132K as of Q2 2026.
  • CG Oncology was a new Aster Capital Management position in Q2 2026.
  • CG Oncology made up 0.03% of Aster Capital Management's portfolio in Q2 2026, its #469 holding.
  • Aster Capital Management first reported a position in CG Oncology in Q1 2025 and has held it in 2 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.